— Know what they know.
Not Investment Advice

PPD NASDAQ

PPD, Inc.
1W: +0.4% 1M: +0.0% 3M: +1.3% 1Y: +33.8%
$47.28
Last traded 2021-12-07 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Cash Flow Trends

Operating Cash Flow
$251M -41.9% ▼
4Y CAGR: -11.4%
Capital Expenditures
$163M -29.7% ▼
4Y CAGR: +16.0%
Free Cash Flow
$88M -71.3% ▼
4Y CAGR: -27.5%
Dividends Paid
$0 +0.0% ▲
Buybacks
$626K +84.4% ▲
Net Change in Cash
$423M +303.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
— Operating Activities —
Net Income$183M$296M$104M$48M$154M
Depreciation & Amort.$260M$279M$259M$265M$279M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$30M-$114M$107M-$426M-$288M
Other Non-Cash Items-$30M$141M-$39M$615M$124M
Operating Cash Flow$408M$359M$423M$433M$251M
— Investing Activities —
Capital Expenditures-$90M-$105M-$116M-$126M-$163M
Acquisitions (Net)-$435M-$24M-$776K-$104M-$20M
Investment Purchases-$6M-$2M-$2M-$4M-$7M
Investment Sales$0$0$0$0$0
Other Investing$11M$38M$28M$956K$44M
Investing Cash Flow-$520M-$93M-$91M-$233M-$146M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased-$1M-$3.3B-$9M-$4M-$626K
Dividends Paid$0$0$0$0$0
Other Financing$130M-$249M-$167M-$422M$281M
Financing Cash Flow$130M-$249M-$167M-$422M$281M
Net Change in Cash-$4M$57M$134M-$208M$423M
Cash End of Period$362M$419M$553M$345M$768M
Free Cash Flow$318M$254M$307M$307M$88M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms